Skip to content
Screener

USANA Health Sciences USNA Q1 2026 earnings

Reported May 5, 2026 · After market close

Revenue$250.0MBeat by $9.0M
EPS$0.61Beat by $0.17
Revenue estimate$241.0M
EPS estimate$0.44

Next report

Oct 28, 2026 (in 3 months)
Revenue estimate$224.7M
EPS estimate$0.43

Financials

Q1 2026

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation & ratios

Valuation

as of 04/04/26
See full
Market cap$351.6M-31.2%
P/S0.4×-0.2×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp

Returns & leverage

See full
Current ratio2.5×+0.5×

Segments

By geography

See full
Greater China$123.3M+3.9%
Americas and Europe$80.9M+6.2%
Southeast Asia Pacific$30.7M-14.2%
North Asia$15.4M-18.9%

By segment

See full
Core Nutritional$204.4M—
Hiya$32.2M-13.3%
Rise$13.7M—

FAQ

When did USANA Health Sciences report Q1 2026 earnings?
USANA Health Sciences (USNA) reported Q1 2026 earnings on May 5, 2026 after market close.
What were USANA Health Sciences's Q1 2026 revenue and EPS?
USANA Health Sciences reported revenue of $250.0M and eps of $0.61 for Q1 2026.
Did USANA Health Sciences beat estimates in Q1 2026?
Revenue beat the consensus estimate of $241.0M by $9.0M. EPS beat the consensus estimate of $0.44 by $0.17.
Where can I find USANA Health Sciences's Q1 2026 SEC filings?
You can read the 8-K earnings release (0000896264-26-000030) and the 10-Q periodic report (0000896264-26-000034) directly on SEC EDGAR. The filing index links above go to sec.gov.